Medication info
Albis Tablets

Albis Tablets

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›84mgTripotassium Bismuth Dicitrate›100mgSucralfate Hydrate›300mg
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
This medication is a round, white film-coated tablet.
Packaging
30 tablets/bottle. 300 tablets/bottle, [For Export] 30 tablets (10 tablets/PTP) x 3
Approval status
Approval withdrawn

MFDS item code 199300694 · Notified 1993.11.06

This product's status changed to Approval withdrawn on 2024.02.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers and gastritis) and Zollinger-Ellison syndrome; prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers and gastritis) and Zollinger-Ellison syndrome; prevention of Mendelson's syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcer
  • gastric ulcer caused by NSAIDs
  • duodenal ulcer caused by NSAIDs.
View approved original text

This medicine is used for the treatment of gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia, and it is effective in preventing postoperative ulcers. It helps treat gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This medication decreases gastric acid secretion, improving inflammation and ulcers. Therefore, it is widely used for the relief and treatment of symptoms related to gastrointestinal diseases.

How to take

Adult dose

Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is preferable to also administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or with poor kidney function. Additionally, it should not be administered to individuals with allergies to this medication or its components, patients with a history of acute porphyria, those who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, newborns, and patients who need to restrict potassium intake. Caution is necessary for patients with liver dysfunction, a history of drug allergies, the elderly, and patients with a history of kidney disease. Elderly patients or those with a history of gastrointestinal ulcers taking NSAIDs should undergo regular testing while using this medication. This medication may conceal symptoms of gastric cancer, so gastric ulcer patients or patients in their middle ages or older with recently new or changed dyspeptic symptoms must confirm malignancy before treatment. Patients with positive Helicobacter pylori infection and gastric/duodenal ulcers require eradication therapy. In critically ill patients, the possibility of gastric stone formation should be considered, and in patients with hypophosphatemia, the aluminum component of this medication may interfere with phosphate absorption. Patients with swallowing difficulties should be aware of the potential respiratory problems after administration of this medication. While taking this medication, rare but severe allergy reactions such as anaphylactic shock can occur, so if any symptoms arise, administration should be stopped immediately, and treatment should be sought. If allergic symptoms such as skin rash, urticaria, angioedema, fever, bronchospasm, hypotension, or chest pain appear, administration should cease. Blood tests may show decreases in white blood cells, platelets, or liver dysfunction, and immediate consultation with a doctor is necessary if any abnormal symptoms occur. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal bloating, and the stool may turn black; however, this can be due to the properties of the medication and does not require treatment. In severe patients or the elderly, neurological symptoms such as dizziness, drowsiness, confusion, seizures, insomnia, headache, anxiety, may develop, necessitating close observation. Muscle pain or joint pain, and rarely severe muscle damage (rhabdomyolysis) may occur; if any abnormal symptoms arise, administration should be stopped. Skin rash, hair loss, itching, or darkened tongue may occur, and if severe skin reactions appear, immediate treatment is required. It is essential to avoid long-term use, and during treatment, regular blood, liver, and kidney functions should be checked, using the minimal effective dose. Elderly patients or those with chronic lung diseases, diabetes, or weakened immune systems are at increased risk of pneumonia when taking this medication and should be cautious. If dizziness or drowsiness occurs during use, driving or hazardous machinery operation should be avoided. This medication may interact with other drugs; if you are taking any other medications, be sure to inform your doctor or pharmacist, and special caution should be taken when using it with anticoagulants or some antibiotics and anticonvulsants. Pregnant or breastfeeding women should not use this medication, and safety in pediatric patients has not been established, so administration is not recommended. This medication may cause false-positive results in urine protein tests, so care should be taken with testing methods. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and in severe cases, removal can be done by hemodialysis. Finally, this medication can reduce gastric acid secretion, which may promote bacterial growth in the stomach; therefore, those on long-term use should consider undergoing ophthalmologic examinations.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 49 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • anorexia
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness perception
  • anxiety
  • mental disturbance
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • hypertonic muscle spasms
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air or moisture ingress. Additionally, avoid excessively hot or cold places, and it is best to store it at normal room temperature.

Appearance and packaging

Appearance

This medication is a round, white film-coated tablet.

Package unit

30 tablets/bottle. 300 tablets/bottle, [For Export] 30 tablets (10 tablets/PTP) x 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.